Astrazeneca Pauses Vaccine Trial
- All
- News
- Videos
-
AstraZeneca UK Vaccine Trial On Children Paused As Clot Link Probed
A British trial of the AstraZeneca coronavirus vaccine on children has been paused while regulators assess its possible link to blood clots, Oxford University, which helped develop the jab, said Tuesday.
-
Oxford Vaccine Trials Resume In UK, Were Paused Over Volunteer's Illness
Pharma giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.
-
Adar Poonawalla's Serum Institute Told To Pause Vaccine Trial Recruitment
New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has to be suspended till further orders, country's drug controller DCGI has said.
-
Serum Institute Ordered To Suspend Recruitment For Covid Vaccine Trials
Drugs Controller General of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate in the backdrop of pharma giant AstraZeneca pausing the trials in other countries.
-
AstraZeneca Vaccine Trial Pause A "Wake-Up Call", Says WHO
AstraZeneca's pause of an experimental vaccine for the coronavirus after the illness of a participant is a "wake-up call" but should not discourage researchers, the World Health Organization's (WHO) chief scientist said on Thursday.
-
Vaccine Still Possible By Year-End Despite Trial Pause, Says AstraZeneca
Drugs giant AstraZeneca on Thursday said a Covid-19 vaccine could still be available by as early as the end of this year, despite a randomised clinical trial in the UK being paused.
-
Adar Poonawalla's Serum Institute Gets Notice on Pausing Vaccine Trial
The Serum Institute of India, which is manufacturing the Oxford University's Covishield vaccine and will hold the phase 3 clinical trials in India from next week, has been issued a showcause notice by the country's drug controller DCGI. Trials for the vaccine were stopped in four nations as a precautionary measure after one of the recipients in the...
-
Safety Paramount In Vaccine Trials, Suspensions "Not Unusual": WHO
Safety is paramount in vaccine clinical trials and temporary suspensions are not unusual to evaluate any unexplained illness in a participant, the World Health Organization (WHO) said on Thursday regarding the pause in an AstraZeneca COVID-19 trial.
-
Vaccine Safety Top Priority, Says WHO As AstraZeneca Pauses Study
Safety of a prospective COVID-19 vaccine comes "first and foremost", the World Health Organization's chief scientist said on Wednesday, as a trial of a leading candidate from AstraZeneca was paused due to concerns over side effects.
-
Oxford Trials Pause Could Disrupt Closely-Watched Race For Vaccine
AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in one of the company's studies got sick, a potential adverse reaction that could delay or derail efforts to speed an immunization against Covid-19.
-
Astrazeneca Pharma India Shares Dive Nearly 7% As Vaccine Trials Paused
The parent company AstraZeneca "voluntarily paused" a randomized clinical trial of its coronavirus vaccine asa volunteer developed an unexplained illness.
-
Trials Of Oxford Vaccine "Paused" After Unexpected Illness In Volunteer
Pharmaceutical company AstraZeneca said Tuesday it had "voluntarily paused" a randomized clinical trial of its coronavirus vaccine in what it called a routine action after a volunteer developed an unexplained illness.
-
AstraZeneca UK Vaccine Trial On Children Paused As Clot Link Probed
A British trial of the AstraZeneca coronavirus vaccine on children has been paused while regulators assess its possible link to blood clots, Oxford University, which helped develop the jab, said Tuesday.
-
Oxford Vaccine Trials Resume In UK, Were Paused Over Volunteer's Illness
Pharma giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.
-
Adar Poonawalla's Serum Institute Told To Pause Vaccine Trial Recruitment
New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has to be suspended till further orders, country's drug controller DCGI has said.
-
Serum Institute Ordered To Suspend Recruitment For Covid Vaccine Trials
Drugs Controller General of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate in the backdrop of pharma giant AstraZeneca pausing the trials in other countries.
-
AstraZeneca Vaccine Trial Pause A "Wake-Up Call", Says WHO
AstraZeneca's pause of an experimental vaccine for the coronavirus after the illness of a participant is a "wake-up call" but should not discourage researchers, the World Health Organization's (WHO) chief scientist said on Thursday.
-
Vaccine Still Possible By Year-End Despite Trial Pause, Says AstraZeneca
Drugs giant AstraZeneca on Thursday said a Covid-19 vaccine could still be available by as early as the end of this year, despite a randomised clinical trial in the UK being paused.
-
Adar Poonawalla's Serum Institute Gets Notice on Pausing Vaccine Trial
The Serum Institute of India, which is manufacturing the Oxford University's Covishield vaccine and will hold the phase 3 clinical trials in India from next week, has been issued a showcause notice by the country's drug controller DCGI. Trials for the vaccine were stopped in four nations as a precautionary measure after one of the recipients in the...
-
Safety Paramount In Vaccine Trials, Suspensions "Not Unusual": WHO
Safety is paramount in vaccine clinical trials and temporary suspensions are not unusual to evaluate any unexplained illness in a participant, the World Health Organization (WHO) said on Thursday regarding the pause in an AstraZeneca COVID-19 trial.
-
Vaccine Safety Top Priority, Says WHO As AstraZeneca Pauses Study
Safety of a prospective COVID-19 vaccine comes "first and foremost", the World Health Organization's chief scientist said on Wednesday, as a trial of a leading candidate from AstraZeneca was paused due to concerns over side effects.
-
Oxford Trials Pause Could Disrupt Closely-Watched Race For Vaccine
AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in one of the company's studies got sick, a potential adverse reaction that could delay or derail efforts to speed an immunization against Covid-19.
-
Astrazeneca Pharma India Shares Dive Nearly 7% As Vaccine Trials Paused
The parent company AstraZeneca "voluntarily paused" a randomized clinical trial of its coronavirus vaccine asa volunteer developed an unexplained illness.
-
Trials Of Oxford Vaccine "Paused" After Unexpected Illness In Volunteer
Pharmaceutical company AstraZeneca said Tuesday it had "voluntarily paused" a randomized clinical trial of its coronavirus vaccine in what it called a routine action after a volunteer developed an unexplained illness.
